Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer-Reference-Cited by-同舟云学术

Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer

Published:2017-01 Issue:2 Volume:292 Page:748-759
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Alexander Peter B.,Chen Rui,Gong Chang,Yuan Lifeng,Jasper Jeff S.,Ding Yi,Markowitz Geoffrey J.,Yang Pengyuan,Xu Xin,McDonnell Donald P.,Song Erwei,Wang Xiao-Fan

Funder

National Institutes of Health

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference53 articles.

1. Global patterns of cancer incidence and mortality rates and trends;Jemal;Cancer Epidemiol. Biomarkers Prev,2010

2. EGF-ERBB signalling: towards the systems level;Citri;Nat. Rev. Mol. Cell Biol,2006

3. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis;Moasser;Oncogene,2007

4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

5. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Cancer,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer;Cancer Research;2024-01-08

2. TAM family kinases as therapeutic targets at the interface of cancer and immunity;Nature Reviews Clinical Oncology;2023-09-04

3. Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands;Frontiers in Medicine;2023-04-17

4. Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer;Frontiers in Pharmacology;2022-12-12

5. The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets;Cancers;2022-10-28